Oral GLP-1: Wegovy pill clinical results, dosing, and availability
Once-daily oral semaglutide 25 mg (Wegovy pill). OASIS trial data, fasting protocol, dose titration, and FDA, MHRA, and EMA approval timelines by region.
Read full article
Plan and track your GLP-1 treatment
Doses, effects, inventory, and goals — in your private cloud.
Made in France · GDPR compliant 
Gloe
Your GLP-1 Treatment Companion
Now: free 1-month trial
Latest from the blog
Retatrutide: Phase 3 results and global availability timeline
Triple GIP/GLP-1/glucagon agonist LY3437943 from Eli Lilly. Phase 3 TRIUMPH results, metabolic effects, and projected FDA, EMA, Japan, Korea, and Latin America timelines.
Read full articleMounjaro reimbursement in France: BMI, HAS, and CSO pathway
Tirzepatide reimbursed at 65% from 15 June 2026. BMI criteria, HAS opinion, CSO or hospital prescription, supplementary insurance co-pay. What it means for GLP-1 tracking.
Read full article